Friday, July 10, 2026

Drug profile · INN

niacinamide

niacinamide (TPN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — niacinamide
US status
approved
Class
Route
ORAL
Patents
0
Programs
3
Data quality
0.84

Quick answer

niacinamide (TPN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN niacinamide
Brand TPN
Route ORAL
Formulation SUSPENSION

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. nicotinamide Phase 2 · Chinese Academy of · Cutaneous Lupus Erythematosus
  2. nicotinamide adenine dinucleotid/nicotinamide mononucleotide Phase 2 · Chinese Academy of · Immune Thrombocytopenia
  3. Nicotinamide Riboside Unknown · United Therapeutics Europe · Gulf War Illness

Frequently asked questions

What is niacinamide?

niacinamide (TPN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for niacinamide?

TPN is a marketed brand name for niacinamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of niacinamide?

niacinamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.